-

Medable to Present at Morgan Stanley Global Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading AI technology platform provider for clinical research, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the Morgan Stanley Global Healthcare Conference in New York City. The presentation will take place on Tuesday, September 9th 7:45 AM Eastern Time.

About Medable

Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our AI-driven platform, including Agent Studio, enhances speed, scale, and patient access in clinical research. Awarded Best Digital Health Solution by the Galien Foundation, Medable’s platform has been deployed in nearly 400 trials in 70 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and was listed for the second year in a row on the Inc. 5000 in 2024.

Contacts

Media Contact:
Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Burak Over, SVP, Corporate Development & Investor Relations, Medable
Burak@medable.com

Industry:

Medable Inc.

Details
Headquarters: Palo Alto, California
CEO: Michelle Longmire
Employees: 350
Organization: PRI
Release Versions
English

Contacts

Media Contact:
Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Burak Over, SVP, Corporate Development & Investor Relations, Medable
Burak@medable.com

Social Media Profiles
Medable on LinkedIn
More News From Medable Inc.

Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes required for trial document management. TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical devel...

Medable Launches Innovation Evidence Workshop – First Collaboration To Bring Leaders Together on DCT Impact, Adoption, and Best Practices

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, the leading provider of AI-powered clinical trial technology, today announced its Innovation Evidence Workshop series, developed in collaboration with and facilitated by the Tufts Center for the Study of Drug Development (Tufts CSDD). Leaders from 20 pharmaceutical, biotech, and contract research organizations (CROs) participated in the inaugural invitation-only workshop held on November 19 in Boston, MA. Programming featured representatives from the...

Medable Named a Leader Amid Growing eCOA Adoption

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical trial technology, today announced it has been named a Leader in Everest Group’s 2025 "Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment." Medable was recognized among 19 vendors for its strong performance across three key areas: buyer priorities, innovation, and future focus. Medable was named a Leader for its continued investment in AI and machine learning to enhance plat...
Back to Newsroom